ÂÜÀòÂÒÂ×

Angelica M. Gomes Ueltschy, PhD, is a seasoned scientist currently serving as the Scientific Director and Lead Scientist for the Mesoderm Program at Trailhead Biosystems since July 2020, where the focus includes developing advanced protocols for differentiating induced pluripotent stem cells (iPSCs) into various blood cell types. Previous experience includes roles as a Research Scientist analyzing data for cell differentiation at Cleveland Clinic, a K12 Scholar studying glycosciences, and a Postdoctoral Researcher investigating breast cancer progression at Tulane University. A background in live cell imaging and gene editing technologies was established during postdoctoral work at the Biotech Research and Innovation Centre in Copenhagen. Angelica's academic journey includes a PhD, an MSc, and a Bachelor's degree from Universidade Federal do Rio de Janeiro, underscoring significant contributions in biochemistry and molecular biology throughout their career.